PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $821,000 | -28.2% | 16,364 | -32.2% | 0.00% | 0.0% |
| Q1 2021 | $1,143,000 | -70.5% | 24,141 | -62.0% | 0.00% | -75.0% |
| Q4 2020 | $3,875,000 | +30.5% | 63,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,969,000 | -4.1% | 63,500 | +4.1% | 0.00% | 0.0% |
| Q2 2020 | $3,095,000 | +26.1% | 61,000 | +10.9% | 0.00% | 0.0% |
| Q1 2020 | $2,454,000 | -7.1% | 55,000 | 0.0% | 0.00% | +33.3% |
| Q4 2019 | $2,642,000 | +52.5% | 55,000 | +7.4% | 0.00% | +50.0% |
| Q3 2019 | $1,732,000 | -16.2% | 51,200 | +11.5% | 0.00% | 0.0% |
| Q2 2019 | $2,066,000 | +161.5% | 45,900 | +118.6% | 0.00% | +100.0% |
| Q1 2019 | $790,000 | +54.9% | 21,000 | +33.5% | 0.00% | 0.0% |
| Q4 2015 | $510,000 | -19.8% | 15,731 | +19.1% | 0.00% | 0.0% |
| Q2 2015 | $636,000 | -51.9% | 13,213 | -39.2% | 0.00% | 0.0% |
| Q1 2015 | $1,322,000 | -6.4% | 21,730 | -20.4% | 0.00% | 0.0% |
| Q4 2014 | $1,413,000 | +53.8% | 27,300 | +30.6% | 0.00% | 0.0% |
| Q3 2014 | $919,000 | – | 20,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |